{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-296659","form_type":"8-K","ticker":"VNDA","cik":"0001347178","company_name":"Vanda Pharmaceuticals Inc.","filed_at":"2023-12-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.717214+00:00","generated_at":"2026-06-07T11:47:12.046316+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"medium","headline":"Vanda amends bylaws to adopt universal proxy rule procedures","bullets":["Board approved restated bylaws on Dec 13, 2023, effective immediately.","Amendments address Rule 14a-19 universal proxy requirements, including 67% voting power solicitation requirement.","Bylaws conform to recent Delaware General Corporation Law changes on adjournment and stockholder lists.","Other technical non-substantive changes included in the restated bylaws."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-296659","json":"https://secwatch.observer/filing/0001193125-23-296659.json","markdown":"https://secwatch.observer/filing/0001193125-23-296659.md","text":"https://secwatch.observer/filing/0001193125-23-296659.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347178/000119312523296659/0001193125-23-296659-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347178/000119312523296659/d35023d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T11:47:12.046316+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"095c067dacf2b9cbadd65c5b3cc78c5996beaf04","claim":"Vanda Pharmaceuticals Inc.: Amended and restated bylaws to address Universal Proxy Rules and conform to Delaware law (effective 2023-12-13).","evidence_excerpt":"On December 13, 2023, the Board of Directors of Vanda Pharmaceuticals Inc. (the “Company”) approved and adopted an amendment and restatement of the Company’s Fourth Amended and Restated Bylaws (the “Bylaws”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1347178/000119312523296659/0001193125-23-296659-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-12-13"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}